Hemophilia Market Revenue, Trends, Market Share Analysis, And Forecast To 2028November 21, 2022 ⚊ 1 Min read ⚊ Views 57 ⚊ NEWS
According to the current analysis of Reports and Data, the global Hemophilia Market was valued at USD 12.41 Billion in 2020 and is expected to reach USD 18.75 Billion by the year 2028, at a CAGR of 5.20%. Hemophilia is a rare genetic disorder in which blood doesn’t clot normally because it lacks sufficient blood-clotting proteins known as clotting factors. Among the types of disorders, type A is anticipated to be multiple times more predominant than type B. The global market for hemophilia drugs is growing significantly, owing to the increasing number of hemophilic patients globally.